United Kingdom · 
Who invested in Quotient Therapeutics?
Quotient Therapeutics's investors include Flagship Pioneering.
United Kingdom · Seed startup
Who invested in Quotient Therapeutics
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2023, from 1 source
- Latest round
- Seed, $50MNov 2023
- Investors
- 1
The rounds
- Nov 2023
Founders and team
From Quotient Therapeutics's own website: 9 on the team.
- Rahul KakkarPresident & CEO
- Andy BayliffeChief Development Officer
- Michelle AveryCFO
- Susan KeefeCFO
- Dan O’ConnellHead of Biology
- Matthew YoungHead of Data Science & AI
- Meg ByrneHead of Research and Strategy Operations
- Hao ZhuBoard of Directors
- Peter CampbellCSO & Academic Cofounder
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Quotient Therapeutics
How much has Quotient Therapeutics raised?
Quotient Therapeutics has raised $50M across 1 round since 2023.
When did Quotient Therapeutics last raise?
Quotient Therapeutics's most recent round was a Seed of $50M in Nov 2023.
What was Quotient Therapeutics's biggest round?
Its most recent round, $50M in Nov 2023, is also its largest on record.
Who backed Quotient Therapeutics first?
Quotient Therapeutics's first round on record, in Nov 2023, was backed by Flagship Pioneering.
What stage is Quotient Therapeutics at?
Quotient Therapeutics's latest named round is a Seed, in Nov 2023.
Where is Quotient Therapeutics based?
Quotient Therapeutics is based in the United Kingdom.
Companies like Quotient Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.